Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb).

被引:0
|
作者
Galli, Giulia
Di Guardo, Lorenza
Cimminiello, Carolina
Cavalieri, Stefano
Rodolfo, Monica
Rivoltini, Licia
Valeri, Barbara
Bono, Aldo
Tolomio, Elena
Del Vecchio, Michele
机构
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e21001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21001
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
    Sahadudheen, K.
    Islam, Md. Rafiqul
    Iddawela, M.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2016, 2016
  • [32] A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)
    Atkinson, Victoria G.
    Quaglino, Pietro
    Aglietta, Massimo
    Del Vecchio, Michele
    Depenni, Roberta
    Consoli, Francesca
    Bafaloukos, Dimitrios
    Ferrucci, Pier Francesco
    Tulyte, Skaiste
    Krajsova, Ivana
    Ascierto, Paolo A.
    Gueli, Rossana
    Arance, Ana
    Gogas, Helen
    Banerjee, Hiya
    Saliba, Teddy
    de Jong, Egbert
    Neyns, Bart
    CANCERS, 2021, 13 (10)
  • [33] Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells
    Fay, J. W.
    Banchereau, J.
    Palucka, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells
    Fay, J. W.
    Banchereau, J. F.
    Palucka, A. K.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 894 - 894
  • [35] Long-term follow-up of multiple myeloma (MM) patients (pts) with osteonecrosis of the jaw (ONJ)
    Badros, Ashraf
    Evangelos, T.
    Goloubeva, O.
    Meiller, T.
    Kastritis, E.
    Verrou, E.
    Zervas, K.
    Katodritou, E.
    Streeten, E.
    Baer, M. R.
    Dimopoulos, M. A.
    BLOOD, 2007, 110 (11) : 1030A - 1031A
  • [36] IS LONG-TERM FOLLOW-UP JUSTIFIED AFTER EXCISION OF A THIN MELANOMA (LESS-THAN-OR-EQUAL-TO 1.5 MM) - A RETROSPECTIVE ANALYSIS OF 206 PATIENTS
    BRANDT, SE
    WELVAART, K
    HERMANS, J
    JOURNAL OF SURGICAL ONCOLOGY, 1990, 43 (03) : 157 - 160
  • [37] LONG-TERM SURVIVAL IN PATIENTS WITH BRAIN METASTASES: A RETROSPECTIVE ANALYSIS
    Juratli, Tareq
    Soucek, Silke
    Kirsch, Matthias
    Schackert, Gabriele
    NEURO-ONCOLOGY, 2013, 15 : 113 - 113
  • [38] Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report
    Lee, Jee Min
    Mehta, Urvi N.
    Dsouza, Ly H.
    Guadagnolo, Beverly Ashleigh
    Sanders, Deborah L.
    Kim, Kevin B.
    MELANOMA RESEARCH, 2013, 23 (02) : 175 - 178
  • [39] Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis
    Pathmanathan, Shivanshan
    Babu, Hari
    Dzienis, Marcin
    Azer, Mary
    Eastgate, Melissa
    PIGMENT CELL & MELANOMA RESEARCH, 2022, 35 (06) : 587 - 594
  • [40] Long-term survival (over 10 years) of inoperable/metastatic GISTs: A retrospective series of 141 patients (pts) of the french sarcoma group (FSG)
    Duffaud, Florence
    Auclin, Edouard
    Italian, Antoine
    Mancini, Julien
    Bertucci, Francois
    Pen, Nicolas
    Pracht, Marc
    Vogin, Guillaume
    Collard, Olivier
    Orripas, Emmanuelle
    Landi, Bruno
    Valentin, Thibaud
    Chaigneau, Loic
    Toulmonde, Maud
    Adenis, Antoine
    Ray-Coquard, Isabelle Laure
    Rios, Maria
    Salas, S. Bastien
    Le Cesne, Axel
    Blay, Jean -Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35